Chemoprevention of Murine Lung Cancer by Gefitinib in Combination with Prostacyclin Synthase Overexpression

INTRODUCTION: We hypothesized that the combination of the EGFR tyrosine kinase inhibitor (TKI) gefitinib with the powerful chemopreventive manipulation of lung specific transgenic prostacyclin synthase (PGIS) overexpression on tumorigenesis in FVB/N mice would result in augmented chemoprevention. MA...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Keith, Robert L., Karoor, Vijaya, Mozer, Anthony B., Hudish, Tyler M., Le, Mysan, Miller, York E.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2010
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3098617/
https://ncbi.nlm.nih.gov/pubmed/20116128
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.lungcan.2010.01.004
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia